Capitainer

Capitainer is a Sweden-based startup founded in 2016, specializing in revolutionizing blood sampling technology. Their slogan, "Convenient and quantitative blood sampling at the fingertip for everyone, everywhere at anytime," encapsulates their mission. The company has developed a cutting-edge microsystem technology, centered around a disposable sampling chip, enabling near-patient blood sampling, particularly suitable for at-home use. The proprietary sampling chip not only allows for the convenient collection of blood samples, but also meters and stores an exact blood volume, enabling quantitative measurements previously unattainable. This innovation is especially valuable for patients requiring continuous therapeutic drug monitoring. Through this, Capitainer aims to address a significant market need, with over a million therapeutic drug monitoring samples taken annually in Sweden alone. Notably, the company secured a kr15.00M Series A investment on 15th February 2024, with participation from We Venture Capital, Sciety Venture Partners, and Sciety. This investment underscores the confidence placed in Capitainer's innovative solution and its potential to revolutionize blood sampling practices, reduce healthcare resource expenditure, and improve patient experience. With its unique technological approach and clear market opportunity, Capitainer is poised to make a substantial impact in the healthcare industry.